Lonza moves ahead with strategic growth in China
Lonza has announced a major investment plan to develop its China operations in Nansha Guangzhou. The company has been operating an R&D facility here since the end of 2005 and will now construct an integrated exclusive synthesis platform with R&D capabilities as well as small and large scale cGMP manufacturing. The small scale plant is due to come on stream this September.
Lonza has announced a major investment plan to develop its China operations in Nansha Guangzhou. The company has been operating an R&D facility here since the end of 2005 and will now construct an integrated exclusive synthesis platform with R&D capabilities as well as small and large scale cGMP manufacturing. The small scale plant is due to come on stream this September.
“This world class facility is designed to accommodate a greater number of reactors including a dedicated and technologically advanced quality control lab capable of fulfilling the ever increasing requirements of global regulatory authorities on the highest possible level,” says Lonza. “In the completed first build-out phase, six smaller reactors including distillation and filtration units are installed, capable of handling a broad range of technologies.”